The hallmarks of mitochondrial dysfunction in chronic kidney disease
3
Publication type: Journal Article
Publication date: 2017-11-01
scimago Q1
wos Q1
SJR: 4.130
CiteScore: 21.4
Impact factor: 12.6
ISSN: 00852538, 15231755
PubMed ID:
28893420
Nephrology
Abstract
Recent advances have led to a greater appreciation of how mitochondrial dysfunction contributes to diverse acute and chronic pathologies. Indeed, mitochondria have received increasing attention as a therapeutic target in a variety of diseases because they serve as key regulatory hubs uniquely situated at crossroads between multiple cellular processes. This review provides an overview of the role of mitochondrial dysfunction in chronic kidney disease, with special emphasis on its role in the development of diabetic nephropathy. We examine the current understanding of the molecular mechanisms that cause mitochondrial dysfunction in the kidney and describe the impact of mitochondrial damage on kidney function. The new concept that mitochondrial shape and structure are closely linked with its function in the kidneys is discussed. Furthermore, the mechanisms that translate cellular cues and demands into mitochondrial remodeling and cellular damage, including the role of microRNAs and long noncoding RNAs, are examined with the final goal of identifying mitochondrial targets to improve treatment of patients with chronic kidney diseases.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
|
|
|
International Journal of Molecular Sciences
22 publications, 6.03%
|
|
|
Frontiers in Pharmacology
12 publications, 3.29%
|
|
|
American Journal of Physiology - Renal Physiology
10 publications, 2.74%
|
|
|
Kidney International
9 publications, 2.47%
|
|
|
Cells
8 publications, 2.19%
|
|
|
Antioxidants
6 publications, 1.64%
|
|
|
Scientific Reports
6 publications, 1.64%
|
|
|
Biomolecules
5 publications, 1.37%
|
|
|
Nutrients
5 publications, 1.37%
|
|
|
Oxidative Medicine and Cellular Longevity
5 publications, 1.37%
|
|
|
International Journal of Molecular Medicine
4 publications, 1.1%
|
|
|
Frontiers in Physiology
4 publications, 1.1%
|
|
|
Cell Death and Disease
4 publications, 1.1%
|
|
|
Kidney International Reports
4 publications, 1.1%
|
|
|
Redox Biology
4 publications, 1.1%
|
|
|
FASEB Journal
4 publications, 1.1%
|
|
|
Kidney Diseases
3 publications, 0.82%
|
|
|
DNA and Cell Biology
3 publications, 0.82%
|
|
|
Clinical Science
3 publications, 0.82%
|
|
|
Toxicology and Industrial Health
3 publications, 0.82%
|
|
|
Renal Failure
3 publications, 0.82%
|
|
|
Frontiers in Medicine
3 publications, 0.82%
|
|
|
BMC Nephrology
3 publications, 0.82%
|
|
|
Biochemical and Biophysical Research Communications
3 publications, 0.82%
|
|
|
International Immunopharmacology
3 publications, 0.82%
|
|
|
Pharmacological Research
3 publications, 0.82%
|
|
|
Biochimica et Biophysica Acta - Molecular Basis of Disease
3 publications, 0.82%
|
|
|
Mitochondrion
3 publications, 0.82%
|
|
|
Free Radical Biology and Medicine
3 publications, 0.82%
|
|
|
5
10
15
20
25
|
Publishers
|
10
20
30
40
50
60
70
80
90
|
|
|
Elsevier
90 publications, 24.66%
|
|
|
MDPI
62 publications, 16.99%
|
|
|
Springer Nature
55 publications, 15.07%
|
|
|
Frontiers Media S.A.
28 publications, 7.67%
|
|
|
Wiley
25 publications, 6.85%
|
|
|
American Physiological Society
10 publications, 2.74%
|
|
|
Taylor & Francis
8 publications, 2.19%
|
|
|
Hindawi Limited
8 publications, 2.19%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
7 publications, 1.92%
|
|
|
Spandidos Publications
6 publications, 1.64%
|
|
|
American Society for Clinical Investigation
4 publications, 1.1%
|
|
|
Mary Ann Liebert
4 publications, 1.1%
|
|
|
American Chemical Society (ACS)
4 publications, 1.1%
|
|
|
Oxford University Press
4 publications, 1.1%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 1.1%
|
|
|
S. Karger AG
3 publications, 0.82%
|
|
|
Portland Press
3 publications, 0.82%
|
|
|
SAGE
3 publications, 0.82%
|
|
|
Public Library of Science (PLoS)
3 publications, 0.82%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
3 publications, 0.82%
|
|
|
The Endocrine Society
2 publications, 0.55%
|
|
|
American Society of Nephrology
2 publications, 0.55%
|
|
|
European Molecular Biology Organization
2 publications, 0.55%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.27%
|
|
|
Bioscientifica
1 publication, 0.27%
|
|
|
IOP Publishing
1 publication, 0.27%
|
|
|
Canadian Science Publishing
1 publication, 0.27%
|
|
|
American Diabetes Association
1 publication, 0.27%
|
|
|
BMJ
1 publication, 0.27%
|
|
|
10
20
30
40
50
60
70
80
90
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
366
Total citations:
366
Citations from 2024:
89
(24.38%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Galvan D. L. et al. The hallmarks of mitochondrial dysfunction in chronic kidney disease // Kidney International. 2017. Vol. 92. No. 5. pp. 1051-1057.
GOST all authors (up to 50)
Copy
Galvan D. L., Green N. H., Danesh F. R. The hallmarks of mitochondrial dysfunction in chronic kidney disease // Kidney International. 2017. Vol. 92. No. 5. pp. 1051-1057.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.kint.2017.05.034
UR - https://doi.org/10.1016/j.kint.2017.05.034
TI - The hallmarks of mitochondrial dysfunction in chronic kidney disease
T2 - Kidney International
AU - Galvan, Daniel L.
AU - Green, Nathanael H.
AU - Danesh, Farhad R.
PY - 2017
DA - 2017/11/01
PB - Elsevier
SP - 1051-1057
IS - 5
VL - 92
PMID - 28893420
SN - 0085-2538
SN - 1523-1755
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Galvan,
author = {Daniel L. Galvan and Nathanael H. Green and Farhad R. Danesh},
title = {The hallmarks of mitochondrial dysfunction in chronic kidney disease},
journal = {Kidney International},
year = {2017},
volume = {92},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.kint.2017.05.034},
number = {5},
pages = {1051--1057},
doi = {10.1016/j.kint.2017.05.034}
}
Cite this
MLA
Copy
Galvan, Daniel L., et al. “The hallmarks of mitochondrial dysfunction in chronic kidney disease.” Kidney International, vol. 92, no. 5, Nov. 2017, pp. 1051-1057. https://doi.org/10.1016/j.kint.2017.05.034.